National Institutes of Health began a competition for low-cost diagnostic technologies to improve maternal health, particularly in low-resource regions. . . . → Read More: NIH Opens $1M Maternal Health Diagnostics Challenge
|
|||||
       
  |
Clinical trial results show a nasal spray treatment for acute migraine helps more users achieve relief from pain within two hours, and faster in some cases. . . . → Read More: Trial Shows Nasal Spray Relieves Migraine Pain 
GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders. . . . → Read More: Oxford, GSK Partner on New Tech for Neuro Diseases 
A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics. . . . → Read More: $180M Venture Fund Backing Age-Related Disease Start-Ups 
A discoverer of synthetic antibodies is asking Food and Drug Administration for clearance to begin a clinical trial of a Covid-19 antibody cocktail therapy. . . . → Read More: Covid-19 Antibody Cocktail Trial Request Filed 
A biotechnology start-up producing proteins with more sustainable and less costly plant-based processes is raising $3 million in its seed funding round. . . . → Read More: Plant-Based Protein Biotech Raises $3M in Seed Funds 
A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA. . . . → Read More: Samsung, Biotech Partner on mRNA Vaccine Production 
A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion. . . . → Read More: Regeneron Gains Cancer, Infectious Disease Immunotherapies  Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, cancer, Covid-19, equity, Europe, investment, licensing, life sciences, pharmaceuticals 
A clinical trial completed enrollment of lung cancer patients testing a device sending an electric field into their tumors to disrupt cancer cell proliferation. . . . → Read More: Trial Advances Test of Electronic Cancer Treatment Comments are closed New products biomedical, cancer, chemistry, clinical trials, engineering, life sciences, medical device, pharmaceuticals, physical sciences, physics, university 
A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding. . . . → Read More: Cell Therapy Start-Up Raises $6M in Seed Funds Comments are closed Finance, New products biomedical, biotechnology, clinical trials, entrepreneurs, equity, investment, life sciences, manufacturing, pharmaceuticals, stem cells, venture capital |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
